Navigation Links
Best Practices for Conducting Extractable and Leachable Studies, new life sciences webinar hosted by Xtalks
Date:5/8/2013

Toronto, Canada (PRWEB) May 08, 2013

Regulatory agencies expect that any container closure systems or components utilized in manufacturing the drug product do not adulterate the product. Appropriately designed extractables studies provide relevant and meaningful data, allowing for a detailed risk assessment.

Several different extraction solutions and analytical techniques may be employed to screen the components of interest for extractable compounds. Care must be taken in evaluating these methods to ensure that potential extractable compounds are capable of being observed.

Webinar attendees will walk away with a strong understanding of:

  •     Strategies for establishing an extractables study design
  •     Risk assessment based on product type
  •     Use of various analytical techniques and their benefits and drawbacks
  •     Tools utilized to handle difficult sample matrices
  •     Tools to handle Threshold of Toxicological Concern (TTC)
  •     Data sources useful for toxicological evaluation
  •     Tools to evaluate Tolerable Intake (TI) and Tolerable Exposure (TE)
  •     Design of studies to monitor leachable compounds

A Q&A with the audience will follow the main presentation.

For more information about this event or to register, visit:
http://xtalks.com/extractable-leachable-eurofins-lancasterlabs.ashx.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com/ContactUs.ashx.

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10699504.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Alacrita Aggregates the Life Science Practices of Two Consulting Firms and Appoints Simon Turner Ph.D FRSC as Partner
2. Best Practices for Lean Six Sigma in Clinical Development and R&D, New Xtalks Life Sciences Webinar
3. Local Leaders Convene in Boston to Share Industry Best Practices in Second “Business of Big Data” Summit
4. BioInformatics LLC New Market Report – Best Practices Guide for Advertising to Life Scientists
5. How to Ensure Pharmacovigilance Practices are Compliant with Global Safety Requirements: Challenges in Asia-Pacific
6. First Suit Against Nobel Prize Organization Citing Defamation And Unfair Competition Practices Is Filed
7. Best Practices, LLC Issues New Report and Webinar on Managing Healthcare Reform through Effective Engagement with the Government Ecosystem
8. Reno Efficient Sustainable Practices Selected to Provide Water and Energy Conservation Services To the County of San Diego
9. Innovation Leaders from Across Industries will Convene to Share Best Practices and Breakthrough Successes at Open Innovation Leadership Summit
10. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
11. Challenges and Solutions in Conducting Biosimilar Trials, New Life Science Webinar Hosted by Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)...  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a clinical ... to commercialize innovative therapeutics for patients with cancer, ... approved for trading on the OTCQX U.S. market. ... effective today, under the ticker symbol "HPPI." ... must meet high financial standards, follow best practice ...
(Date:12/8/2016)... Dec. 8, 2016 Eutilex Co. Ltd. today ... (US $18.9M) Series A financing. This financing round included ... Venture and SNU Bio Angel. This new funding brings ... KRW (US $27.7M) since its founding in 2015. ... the development and commercialization of its immuno-oncology programs, expand ...
(Date:12/8/2016)... Dec. 8, 2016   Biocept, Inc . ... provider of clinically actionable liquid biopsy tests to ... clinical data featuring its Target Selector™ Circulating Tumor ... for the detection of actionable biomarkers in patients ... sponsored by Sara Cannon Research Institute (SCRI), the ...
(Date:12/7/2016)... ... December 07, 2016 , ... A new ... the setting of previously treated, advanced pancreatic cancer, liquid biopsies are not yet ... population and timing of blood sampling may improve the value of a blood-based ...
Breaking Biology Technology:
(Date:11/22/2016)... November 22, 2016 According to the new market ... Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact ... MarketsandMarkets, the market is expected to grow from USD 10.74 Billion in ... 16.79% between 2016 and 2022. Continue Reading ... ...
(Date:11/17/2016)... CITY OF INDUSTRY, Calif. , Nov. 17, 2016  AIC announces that it ... about using NVMe storage servers in organizations that require high-performance scale-out plus high speed data transfer ... ... ... Setting ...
(Date:11/14/2016)... , Nov. 14, 2016  Based on ... market, Frost & Sullivan recognizes FST Biometrics ... Award for Visionary Innovation Leadership. FST Biometrics ... biometric identification market by pioneering In Motion ... for instant, seamless, and non-invasive verification. This ...
Breaking Biology News(10 mins):